Ampyra’s Agressive Free Trial Promotion to Patients
![](https://oncedailypharma.com/wp-content/uploads/2017/04/ampyra-free-product-trial.jpeg)
Brand: Ampyra (dalfampridine), Tablets
Parent Company: Acorda Therapeutics
Drug Type: Prescription
Drug Category: Neurology
Campaign: Post-Launch
Targeting: Patients, Caregivers
Patient Website: https://ampyra.com/
HCP Website: https://ampyra-hcp.com/